According to Firebrick Pharma latest financial reports the cash on hand of FRE is $1.59M, an decrease of -67.04% to 2022. At the end of 2022 company had $4.83M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.59M | -67.04% |
2022 | $4.83M | -35.99% |
2021 | $7.55M | - |